OBJECTIVE: To assess whether a downhill walking training programme is more effective than the same amount of training applied uphill in chronic stroke survivors. DESIGN: Randomized, single-blind study. SETTING: Outpatient rehabilitation service. METHODS:Thirty-eight adults with hemiplegia from stroke lasting more than three months were randomly allocated to one of the two groups: 'UP' - 45 minutes of physical therapy + 30 minutes of treadmill with 5% ascending slope; and 'DOWN' - 45 minutes of physical therapy + 30 minutes of treadmill with 5% descending slope. Both groups were treated 5 times a week for six weeks. Patients were evaluated before treatment, at the end of treatment and after three months. OUTCOME MEASURES: Primary outcome measure was the number of patients showing an improvement in 6-minute walking test (6MWT) greater than 50 m. Secondary outcome measures were: (1) number of patients showing a clinically relevant improvement of gait speed during 10-m walking test (10mWT); (2) number of patients showing an improvement in timed up and go (TUG) greater than minimal detectable change. RESULTS: Both groups had a significant improvement after treatment and at follow-up. At the end of treatment, compared to UP group, more patients in the DOWN group showed clinically significant improvements in primary and secondary outcomes (16/19 patients for 6MWT, 11/19 patients for 10mWT and 9/19 patients for TUG compared with 3/19, 4/19 and 2/19 patients, respectively, P < 0.01). At follow-up, results were similar except for 10mWT. CONCLUSIONS: In chronic stroke patients, downhill treadmill training produces a bigger effect than uphill training.
RCT Entities:
OBJECTIVE: To assess whether a downhill walking training programme is more effective than the same amount of training applied uphill in chronic stroke survivors. DESIGN: Randomized, single-blind study. SETTING:Outpatient rehabilitation service. METHODS: Thirty-eight adults with hemiplegia from stroke lasting more than three months were randomly allocated to one of the two groups: 'UP' - 45 minutes of physical therapy + 30 minutes of treadmill with 5% ascending slope; and 'DOWN' - 45 minutes of physical therapy + 30 minutes of treadmill with 5% descending slope. Both groups were treated 5 times a week for six weeks. Patients were evaluated before treatment, at the end of treatment and after three months. OUTCOME MEASURES: Primary outcome measure was the number of patients showing an improvement in 6-minute walking test (6MWT) greater than 50 m. Secondary outcome measures were: (1) number of patients showing a clinically relevant improvement of gait speed during 10-m walking test (10mWT); (2) number of patients showing an improvement in timed up and go (TUG) greater than minimal detectable change. RESULTS: Both groups had a significant improvement after treatment and at follow-up. At the end of treatment, compared to UP group, more patients in the DOWN group showed clinically significant improvements in primary and secondary outcomes (16/19 patients for 6MWT, 11/19 patients for 10mWT and 9/19 patients for TUG compared with 3/19, 4/19 and 2/19 patients, respectively, P < 0.01). At follow-up, results were similar except for 10mWT. CONCLUSIONS: In chronic strokepatients, downhill treadmill training produces a bigger effect than uphill training.
Authors: Denise M Peters; Yann Thibaudier; Joan E Deffeyes; Gila T Baer; Heather B Hayes; Randy D Trumbower Journal: J Neurotrauma Date: 2017-10-27 Impact factor: 5.269
Authors: Ling-Fung Yeung; Cathy C Y Lau; Charles W K Lai; Yannie O Y Soo; Man-Lok Chan; Raymond K Y Tong Journal: J Neuroeng Rehabil Date: 2021-01-29 Impact factor: 4.262
Authors: Susan Marzolini; Che-Yuan Wu; Rowaida Hussein; Lisa Y Xiong; Suban Kangatharan; Ardit Peni; Christopher R Cooper; Kylie S K Lau; Ghislaine Nzodjou Makhdoom; Maureen Pakosh; Stephanie A Zaban; Michelle M Nguyen; Mohammad Amin Banihashemi; Walter Swardfager Journal: J Am Heart Assoc Date: 2021-12-16 Impact factor: 6.106
Authors: Bernadette C Ammann; Ruud H Knols; Pierrette Baschung; Rob A de Bie; Eling D de Bruin Journal: BMC Neurol Date: 2014-08-22 Impact factor: 2.474